相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Oral Anticoagulant Prescription Trends, Profile Use, and Determinants of Adherence in Patients with Atrial Fibrillation
Sylvie Perreault et al.
PHARMACOTHERAPY (2020)
Metabolic and Pharmaceutical Aspects of Fluorinated Compounds
Benjamin M. Johnson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Discovery of a High Affinity, Orally Bioavailable Macrocyclic FXIa Inhibitor with Antithrombotic Activity in Preclinical Species
Wu Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
A Decade in the MIST: Learnings from Investigations of Drug Metabolites in Drug Development under the Metabolites in Safety Testing Regulatory Guidance
Simone Schadt et al.
DRUG METABOLISM AND DISPOSITION (2018)
An update on factor XI structure and function
Bassem M. Mohammed et al.
THROMBOSIS RESEARCH (2018)
Drug metabolism in drug discovery and development
Zhoupeng Zhang et al.
ACTA PHARMACEUTICA SINICA B (2018)
Bleeding in patients receiving non-vitamin K oral anticoagulants: clinical trial evidence
Arthur Bracey et al.
THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE (2018)
Organic Carbamates in Drug Design and Medicinal Chemistry
Arun K. Ghosh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Metabolism and bioactivation of famitinib, a novel inhibitor of receptor tyrosine kinase, in cancer patients
Cen Xie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Bioactivation of the Epidermal Growth Factor Receptor Inhibitor Gefitinib: Implications for Pulmonary and Hepatic Toxicities
Xiaohai Li et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
In Vitro Metabolism of Rivaroxaban, an Oral, Direct Factor Xa Inhibitor, in Liver Microsomes and Hepatocytes of Rats, Dogs, and Humans
D. Lang et al.
DRUG METABOLISM AND DISPOSITION (2009)
Characterization of Dasatinib and Its Structural Analogs as CYP3A4 Mechanism-Based Inactivators and the Proposed Bioactivation Pathways
Xiaohai Li et al.
DRUG METABOLISM AND DISPOSITION (2009)
Drug-protein adducts: An industry perspective on minimizing the potential for drug bioactivation in drug discovery and development
DC Evans et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2004)
In vitro approaches to evaluate ADMET drug properties
AP Li
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2004)
Addressing the metabolic activation potential of new leads in drug discovery: a case study using ion trap mass spectrometry and tritium labeling techniques
K Samuel et al.
JOURNAL OF MASS SPECTROMETRY (2003)
The role of absorption, distribution, metabolism, excretion and toxicity in drug discovery
J Lin et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2003)
Comparison of in vitro preparations for semi-quantitative prediction of in vivo drug metabolism
IAM De Graaf et al.
DRUG METABOLISM AND DISPOSITION (2002)
Delineating novel metabolic pathways of DPC 963, a non-nucleoside reverse transcriptase inhibitor, in rats. characterization of glutathione conjugates of postulated oxirene and benzoquinone imine intermediates by LC/MS and LC/NMR
H Chen et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2002)
Metabolism of fluorine-containing drugs
BK Park et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
分享论文
